Alzahrani AS, Benito A, Alghamdi B, Alqahtani A, et al. Exceptional and Durable Response to Selpercatinib in a Patient with Apparently RET-Negative, HRAS-, and NF1-Mutated Metastatic Medullary Thyroid Carcinoma. Thyroid 2026 Oct 1:10507256261493665. doi: 10.1177/10507256261493665.
PMID: 42820254